glp-1 employer healthcare costs Nomi Health reports 253% increase in medications | Nomi Health posted on the topic First GLP-1 Pills have Arrived
Description
Oral semaglutide: first-in-class oral GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus
Kultima, J
Our study population included patients who had recent medical encounters for the diagnosis of obesity or T2D and were subsequently prescribed semaglutide or other anti-obesity or anti-diabetes medications, suggesting that patients had active obesity or T2D that needed medical attention and treatments
[DOI] [PMC free article] [PubMed] [Google Scholar] 14.Karhunen L J, Lappalainen R I, Haffner S M, Valve R H, Tuorila H, Miettinen H, Uusitupa M I
Some clinicians are experimenting with dose reduction after goal weight is achieved
If you suspect an adverse reaction to Ozempic, you can report it through the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or via the Yellow Card app)
